Claudio Martines

Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2

Mart Bittremieux, Rita M. La Rovere, Haidar Akl et al. · Cell Death and Differentiation · 2018 · 81 citations · Full text

B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation

Supriya Chakraborty, Claudio Martines, Fabiola Porro et al. · Blood · 2021 · 64 citations · Full text

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma

Binu K. Sasi, Claudio Martines, Elena Xerxa et al. · Leukemia · 2019 · 29 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +7

Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo

Claudio Martines, Supriya Chakraborty, Marija Vujovikј et al. · Blood · 2022 · 25 citations · Full text

ABT‐199 (Venetoclax), a BH3‐mimetic Bcl‐2 inhibitor, does not cause Ca²⁺‐signalling dysregulation or toxicity in pancreatic acinar cells

Monika A. Jakubowska, Martijn Kerkhofs, Claudio Martines et al. · British Journal of Pharmacology · 2018 · 24 citations · Full text